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KATZ, R. J., B. J. CARROLL AND G. BALDRIGHI. Behavioral activation by enkephalins in mice. PHARMAC. 
BIOCHEM. BEHAV. 8(4) 493-496, 1978. - Intraventricular injection of long lasting enkephalin analogues (D-Ala 2 Leu 
and Met enkephalin-amides) produced a sustained elevation of psychomotor activity in mice. The motor syndromes were 
characterized by continual stereotyped activity and were reversed by naloxone pretreatment. Naloxone administered to a 
separate group of mice reduced the initial activation seen after exposure to a novel environment. The present findings 
suggest one or more endogenous opiates normally facilitates behavioral excitation in mice. 
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MORPHINE and its related narcotic analgesic drugs 
produce a variety of  behavioral effects. In most 
species the response to opiates is behavioral sedation 
and somnolence. Some well-known exceptions occur, 
however, particularly in rats (at low dosages only), 
cats, mice, horses and some humans [2, 6, 7]. In 
these species excitement and increased motor  activity 
are observed after morphine injections. This phenom- 
enon can be studied most easily in mice, which 
display a highly stereotyped running response, Straub 
tails, a virtually complete absence of  rearing activity, 
and a profound oblivion to external objects [1,2]. 
S e v e r a l  e n d o g e n o u s  pep t ides  with opiate-like 
activity (enkephalins) have recently been identified [3, 
4, 8, 10, 13, 14, 15]. Methionine enkephalin can 
produce analgesia, tolerance and dependence [1, 3, 
14]. Leucine enkephalin is self-administered strongly 
by animals which also self-administer morphine [12]. 
Several recent reports suggest that enkephalins and 
enkephalin analogues may facilitate the behavioral 
activation induced by other psychoactive compounds, 
or themselves induce a state of increased motor  
activity [5, 9, 10, 15]. Since reports noting a direct 
effect of enkephalins upon activity have generally 
reported these changes as incidental observations with 
l i m i t e d  statistical description (e.g., [10,15]),  we 
examined the ability of enkephalins to produce the 
behavioral activation typically caused by morphine in 
mice .  To maximize behavioral effects, we used 
a n a l o g u e s  w h i c h  are known to have extended 
biological and behavioral activity [3,5]. Enkephalin 
analogues were injected directly into the cerebral 
ventricles. 
METHOD AND P R O C E D U R E  
N i n e t y - s e v e n  a d u l t  ma le  Swiss-Webster mice, 
weighing 2 5 - 3 5 g  (Charles River, Portage, Michigan) 
were maintained on standard ad lib diets (Wayne Lab 
Blocks) and a 12112 light-dark cycle. A ventricular 
cannula of our own design was implanted under 
s o d i u m  p e n t o b a r b i t a l  anaes thes ia .  The cannula 
consisted of a 23 ga stainless steel needle with an 
indwelling obturator and was aimed at the third 
ventricle. The needle was attached to the skull with 
acrylic dental cement reinforced by three stainless steel 
screws. During the week after surgery each mouse was 
placed in the testing cage for five two-hour sessions to allow 
habituation. During drug-administration sessions each 
mouse was placed in the testing cage for one hour of initial 
habituation and baseline activity recording before the drug 
was injected. One additional group of 12 mice was not 
habituated, and was used to assess the effects of naloxone 
upon initial motor activity. Motor activity was recorded 
with four field-sensitive platforms (Stoelting, Chicago, SA 
1566, 1666, 1583, 1454) calibrated to within 5% of each 
other. Mice were placed individually in polypropylene cages 
(Scientific Products Series 70, 51 x 41 x 22 cm) which 
rested directly on the recording platforms. Fresh pine chip 
bedding was placed in each cage. The activity of each 
mouse wasrecorded  in 10 min intervals for 120 min after 
drug administration. The vehicle used for all injections was 
Ringer-Locke solution. Injections were performed manually 
with a Hamilton micro-syringe, using a fixed volume of 
10 ul. This procedure took less than 30 sec to complete. We 
tested the D-Alanine  2 analogues of both methionine- 
and leucine-enkephalinamides (Peninsula Laboratiores, San 
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FIG. L Effects o f  intraventricular D - A I a  2-1eucine enkephalinamide upon motor  act ivi ty in mice. The 
median act ivi ty o f  each group at each time point is displayed. 
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FIG. 2. Effects of  intraventricular D - A I a  2 -methionine enkephalinamide upon motor  activity of mice. 
The median activity of  each group at each time point is displayed. Insert: Normal response of mice to 
intraperitoneal morphine 50 mg/kg. 
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FIG. 3. Effects of Naloxone (4 and 8 mg/kg) on activity response of mice to intraventncular 
D-Ala  2 -leucine enkephlinamide 25 #g (L25). N = Naloxone. R = Ringer-Locke solution. All scores are 
displayed as median percent of L25 response. 
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FIG. 4. Effects of naloxone (8 mg/kg) on activity of mice in comparison with control. All activity 
represents initial behavioral response to the recording apparatus. 
Carlos, Cal ifornia ,  No. 8613 ,  8619) ,  each at four  doses:  
6 .25,  12.5, 25 .0  and  50.0 #g. These  c o m p o u n d s  were used 
wi th in  48 hr  o f  p r epa r a t i on ,  and  were s tored  in t e f lon  
coa ted  con ta ine r s  at 4 .0°C un t i l  in jec t ion .  These  com- 
p o u n d s  occupy  m o r p h i n e  r ecep to r s  b u t  have a longer  
du ra t i on  o f  ac t ion  t han  e n d o g e n o u s  enkepha l in s  since t h e y  
are less rapidly  ca tabo l ized  [ 3 ] .  For  some e x p e r i m e n t s  
n a l o x o n e  (0, 4 or  8 mg/kg)  was in jec ted  IP (10  ml /kg )  
e i the r  by  i tsel f  or 15 min  before  25 #g of  D - A l a n i n e  2 
leucine e n k e p h a l i n a m i d e  or  vehicle.  
RESULTS 
The  resul ts  are s h o w n  in Figs. 1 - 4 .  Figure 1 presen ts  the  
effects  of  the  leu-analogue,  while Fig. 2 p resen t s  met -  
ana logue  effects.  Bo th  e n k e p h a l i n  ana logues  p r o d u c e d  
hyperac t iv i ty .  The  leu-analogue was more  p o t e n t  t h a n  the  
met -ana logue  at all bu t  the  highest  dose. Bo th  drugs 
p r o d u c e d  dose-rela ted increases in behavior ,  a l t hough  leu- 
showed  a relat ive decl ine  at  the  h ighes t  dose. Two way 
repea ted  measures  analysis  o f  var iance ind ica ted  s ignif icant  
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effects  o f  drugs, Fleu(4,41 ) = 9.97, Fmet (4 ,39)  = 13.76; 
p<0 .01 ,  t ime,  Fleu ( 2 1 , 8 6 1 ) =  4.76, Fmet  (21,819)  = 22.7, 
p<0 .001  and in teract ion,  Fleu (84,861)  = 3.89, Fmet  
(84,819)  = 9.93, p<0 .001 ,  By visual observat ion,  bo th  
enkephal in  analogues p roduced  a s te reo typed  running 
syndrome which closely resembled morph ine  running [6] .  
Figure 3 indicates that ,  under  condi t ions  of  extensive 
hab i tua t ion  (i.e., low or no normal  act ivi ty) ,  na loxone  was 
wi thou t  effect  on spontaneous  mo to r  act ivi ty,  and 2) nalo- 
xone  prevented  the running response to int raventr icular  
leucine enkephal in  analogue (U = 4,3, respectively,  for 4 
and 8 mg/kg na loxone ,  p<0 .01  - Mann Whitney U test) 
[ l O l .  
On the o ther  hand,  this cannot  be taken as an indicat ion 
that  na loxone  is wi thou t  effect .  Under  condi t ions  of  
normal ly  high act ivi ty  (initial cage exposure prior to 
habi tuat ion) ,  na loxone  (8 mg/kg) p roduced  a significant 
reduc t ion  in m o t o r  act ivi ty  in compar ison  with a vehicle 
injected cont ro l  group which was matched  for act ivi ty  at 
minute  30. This decline was significant, F(1 ,10)  = 6.79 
(drug), F(10,90)  = 1.77 ( t ime) ,  F(9 ,90)  = 8.72 (inter- 
act ion),  p<0 .05 ,  >0 .05 ,  <0 .01 ,  respectively).  
DISCUSSION 
Our findings suggest enkephal in  analogues cont r ibute  to 
the act ivat ion responses o f  mice. The results with na loxone  
fur ther  suggest the involvement  of  an opiate receptor  in our  
effects.  The results with na loxone  on initially active animals 
also suggest the involvement  of  some opiate-like compound  
in the cont ro l  o f  behavioral  activation.  The present  model  
of  opiate induced act ivat ion represents a highly specific and 
quant i f iable  act ion of  enkephalins which may prove useful 
in the fur ther  psychopharmacologica l  analysis of  the 
actions o f  endogenous  opiates and their  relationships with 
neural and behavioral  systems. 
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